Skip to content

Boston Trust Walden Corp: CHKP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Boston Trust Walden Corp on CHKP, newest first. How the timeline and the estimate are built.

Boston Trust Walden Corp held 1,011,255 CHKP shares at 2026-06-30 per its 13F-HR filed 2026-08-04.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,011,255 shares
    Change vs previous 13F -2,074,068 shares

    0.11% of the 13F portfolio, value $132,937,807.

    13F-HR 0001386060-26-000035 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 1,002,539 shares
    • Boston Trust Walden Corp: 8,716 shares

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 3,085,323 shares
    Change vs previous 13F +231,935 shares

    0.41% of the 13F portfolio, value $440,806,301.

    13F-HR 0001386060-26-000017 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,794,400 shares
    • Boston Trust Walden Corp: 290,923 shares

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 2,853,388 shares
    Change vs previous 13F -77,365 shares

    0.48% of the 13F portfolio, value $529,491,880.

    13F-HR 0001386060-26-000014 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,504,690 shares
    • Boston Trust Walden Corp: 348,698 shares

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 2,930,753 shares
    Change vs previous 13F -392,527 shares

    0.55% of the 13F portfolio, value $606,591,798.

    13F-HR 0001386060-25-000020 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,562,702 shares
    • Boston Trust Walden Corp: 368,051 shares

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F/A 3,323,280 shares
    Change vs previous 13F -546,505 shares

    0.71% of the 13F portfolio, value $734,732,702.

    13F-HR/A 0001085146-25-004915 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 2,935,598 shares
    • Boston Trust Walden Corp: 387,682 shares

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 3,869,785 shares
    Change vs previous 13F -135,588 shares

    0.91% of the 13F portfolio, value $881,790,683.

    13F-HR 0001085146-25-002987 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,447,926 shares
    • Boston Trust Walden Corp: 421,859 shares

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 4,005,373 shares
    Change vs previous 13F +46,666 shares

    0.78% of the 13F portfolio, value $747,913,533.

    13F-HR 0001085146-25-000961 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,518,090 shares
    • Boston Trust Walden Corp: 487,283 shares

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 3,958,707 shares
    Change vs previous 13F not available

    0.77% of the 13F portfolio, value $763,465,010.

    13F-HR 0001085146-24-005518 filed by Boston Partners
    Filed (acceptance time not in the bulk data set), ingested

    • Boston Partners: 3,574,812 shares
    • Boston Trust Walden Corp: 383,895 shares

    Acceptance time not in the bulk data set (spec §4.2).